Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for FSPKF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for FSPKF and 80,000+ other tickers.
See exactly how FSPKF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FSPKF and 80,000+ other tickers.
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, specializes in the global development, manufacturing, marketing, and distribution of sophisticated medical device products and systems. The company's offerings are crucial for acute and chronic respiratory care, surgical support, and the management of obstructive sleep apnea (OSA) in both clinical and home environments. Its product portfolio features advanced solutions such as the Airvo 2 humidified high-flow nasal system, Optiflow nasal high-flow therapy, and the F&P 850 System for both non-invasive and invasive…
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Shareholder/Analyst Call Transcript
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2026 Earnings Call Transcript
Fisher and Paykel Healthcare Co. Limited (OTCMKTS:FSPKF - Get Free Report) fell 17.3% during trading on Wednesday. The company traded as low as $19.01 and last traded at $19.01. 1,455 shares changed hands during mid-day trading, an increase of 37% from the average session volume of 1,063 shares. The stock had previously closed at
Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2026 Earnings Call November 25, 2025 4:00 PM EST Company Participants Marcus Driller - Vice President of Corporate Lewis Gradon - MD, CEO & Executive Director Lyndal York - Chief Financial Officer Justin Callahan - VP of Sales & Marketing Conference Call Participants Lyanne Harrison - BofA Securities, Research Division Dan Hurren - MST Financial Services Pty Limited, Research Division Stephen Ridgewell - Craigs Investment Partners Limited, Research Division Davinthra Thillainathan - Goldman Sachs Group, Inc., Research Division Vanessa Thomson - Jefferies LLC, Research Division Matt Montgomerie - Forsyth Barr Group Ltd., Research Division Craig Wong-Pan - RBC Capital Markets, Research Division Saul Hadassin - Barrenjoey Markets Pty Limited, Research Division Marcus Curley - UBS Investment Bank, Research Division Andrew Paine - CLSA Limited, Research Division Adrian Allbon - Jarden Limited, Research Division David Bailey - Morgan Stanley, Research Division Christine Trinh - Macquarie Research Presentation Operator Welcome to Fisher & Paykel Healthcare's Results Conference Call.
Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q4 2025 Earnings Conference Call May 27, 2025 6:00 PM ET Company Participants Marcus Driller - Vice President of Corporate Lewis Gradon - Chief Executive Officer Lyndal York - Chief Financial Officer Justin Callahan - Vice President of Sales and Marketing Conference Call Participants Davinthra Thillainathan - Goldman Sachs Group, Inc. Lyanne Harrison - Bank of America Merrill Lynch Daniel Hurren - MST Marquee Craig Wong-Pan - RBC Capital Markets Adrian Allbon - Jarden Limited Sacha Krien - Evans and Partners Stephen Ridgewell - Craigs Investment Partners Andrew Paine - CLSA Marcus Curley - UBS Matt Montgomerie - Forsyth Barr Saul Hadassin - Barrenjoey Markets Vanessa Thomson - Jefferies Operator Welcome to the Fisher & Paykel Healthcare's Results Conference Call. My name is Justin, and I'll be your operator for today's call.